Effect of Differences in MIC Values on Clinical Outcomes in Patients with Bloodstream Infections Caused by Gram-Negative Organisms Treated with Levofloxacin

Emerging evidence suggests that current fluoroquinolone dosing strategies may be inadequate to treat bloodstream infections caused by organisms classified as sensitive. This study sought to determine if differences in MICs for levofloxacin-susceptible gram-negative organisms correlate with differenc...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: DeFife, Robyn, Scheetz, Marc H., Feinglass, Joe M., Postelnick, Michael J., Scarsi, Kimberly K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology (ASM) 2009
Gaiak:
Clinical Therapeutics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2650520/
https://ncbi.nlm.nih.gov/pubmed/19075047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00580-08
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak